Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells-Reference-Cited by-同舟云学术

Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells

Published:2017-10-30 Issue:2 Volume:73 Page:414-424
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Brunati Cristina¹²,Thomsen Thomas T³,Gaspari Eleonora¹,Maffioli Sonia¹,Sosio Margherita¹²,Jabes Daniela¹,Løbner-Olesen Anders³,Donadio Stefano¹²

Affiliation:

1. NAICONS Srl, Viale Ortles 22/4, 20139 Milano, Italy

2. KtedoGen Srl, Viale Ortles 22/4, 20139 Milano, Italy

3. Department of Biology, University of Copenhagen, Ole Maaløe’s Vej 5, 2200 Copenhagen, Denmark

Funder

DFF

Danish National Research Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/2/414/24332450/dkx395.pdf

Reference43 articles.

1. Antibacterial drug discovery in the resistance era;Brown;Nature,2016

2. Antimicrobial resistance;Marston;JAMA,2016

3. Antibiotics in the clinical pipeline in 2013;Butler;J Antibiot,2013

4. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE;Rice;J Infect Dis,2009

5. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005;Liu;Clin Infect Dis,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ramoplanin as a novel therapy for Neisseria gonorrhoeae infection: an in vitro and in vivo study in Galleria mellonella;Journal of Medical Microbiology;2024-01-12

2. Microbisporicin (NAI-107) protects Galleria mellonella from infection with Neisseria gonorrhoeae;Microbiology Spectrum;2023-12-12

3. The untapped potential of actinobacterial lanthipeptides as therapeutic agents;Molecular Biology Reports;2023-11-07

4. Antimicrobial peptide antibiotics against multidrug-resistant ESKAPE pathogens;Antimicrobial Peptides;2023

5. Development of recombinant lantibiotics and their potent uses;Lantibiotics as Alternative Therapeutics;2023